LongBio Pharma (Suzhou/Shanghai, founded 2020) is a Chinese clinical-stage biopharmaceutical company focused on the in-house discovery and development of innovative antibody and fusion-protein therapeutics for allergic, autoimmune, and complement-mediated diseases. - View it on GitHub